These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 443942)

  • 21. Clinical and pathophysiologic changes in patients on chronic dialysis: the central nervous system.
    Kerr DN
    Adv Nephrol Necker Hosp; 1980; 9():109-32. PubMed ID: 6773310
    [No Abstract]   [Full Text] [Related]  

  • 22. Dialysis dementia: the role of dialysate pH in altering the dialyzability of aluminum.
    Gacek EM; Babb AL; Uvelli DA; Fry DL; Scribner BH
    Trans Am Soc Artif Intern Organs; 1979; 25():409-15. PubMed ID: 43004
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolic encephalopathy as a complication of renal failure: mechanisms and mediators.
    Fraser CL; Arieff AI
    New Horiz; 1994 Nov; 2(4):518-26. PubMed ID: 7804801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aluminium studies in dialysis encephalopathy.
    Elliott HL; Macdougall AI
    Proc Eur Dial Transplant Assoc; 1978; 15():157-63. PubMed ID: 740662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.
    Lillevang ST; Pedersen FB
    Nephrol Dial Transplant; 1989; 4(7):676. PubMed ID: 2510071
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of desferrioximine in dialysis-associated aluminium disease.
    Ackrill P; Day JP
    Contrib Nephrol; 1993; 102():125-34. PubMed ID: 8416177
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neurologic complications in hemodialysis patients].
    Goulon-Goeau C; Saïd G
    Rev Prat; 1990 Mar; 40(7):644-6. PubMed ID: 2326590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive dialysis encephalopathy from dialysate aluminum.
    Rozas VV; Port FK; Rutt WM
    Arch Intern Med; 1978 Sep; 138(9):1375-7. PubMed ID: 686928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole body aluminium in chronic renal failure and dialysis encephalopathy.
    Williams ED; Elliott HL; Boddy K; Haywood JK; Henderson IS; Harvey I; Kennedy AC
    Clin Nephrol; 1980 Oct; 14(4):198-200. PubMed ID: 6775855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aluminum intoxication of bone in renal failure--fact or fiction?
    Malluche HH; Faugere MC; Smith AJ; Friedler RM
    Kidney Int Suppl; 1986 Feb; 18():S70-3. PubMed ID: 3458000
    [No Abstract]   [Full Text] [Related]  

  • 31. Epidemic dialysis encephalopathy.
    Hocken AG
    Clin Nephrol; 1984 Feb; 21(2):140. PubMed ID: 6723114
    [No Abstract]   [Full Text] [Related]  

  • 32. [Adynamic bone disease in kidney failure. Role of aluminum].
    Cohen-Solal ME; Sebert JL; Morinière P; Fournier A
    Rev Rhum Ed Fr; 1993 May; 60(5):361-4. PubMed ID: 8167643
    [No Abstract]   [Full Text] [Related]  

  • 33. [Myoclonic encephalopathy in dialysis patients].
    Demarcq JM; Delbar M; Prudhomme M; Azar R
    Nouv Presse Med; 1982 Feb; 11(6):456. PubMed ID: 7063386
    [No Abstract]   [Full Text] [Related]  

  • 34. Dialysis encephalopathy.
    Alfrey AC
    Kidney Int Suppl; 1986 Feb; 18():S53-7. PubMed ID: 3457997
    [No Abstract]   [Full Text] [Related]  

  • 35. Dialysis encephalopathy and aluminum exposure: an epidemiologic analysis.
    Schreeder MT; Favero MS; Hughes JR; Petersen NJ; Bennett PH; Maynard JE
    J Chronic Dis; 1983; 36(8):581-93. PubMed ID: 6885959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure.
    Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H
    Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of plasma aluminum in the detection and prevention of aluminum toxicity.
    Winney RJ; Cowie JF; Robson JS
    Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005
    [No Abstract]   [Full Text] [Related]  

  • 38. [Progressive myoclonic encephalopathy in dialysis patients: presence of high concentrations of aluminium in the lysosomes of the cerebral cells (author's transl)].
    Galle P; Chatel M; Berry JP; Menault F
    Nouv Presse Med; 1979 Dec; 8(50):4091-4. PubMed ID: 530824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aluminum and phosphate.
    Kaye M; Turner M; Ardila M; Wiegmann T; Hodsman A
    Kidney Int Suppl; 1988 Mar; 24():S172-4. PubMed ID: 3163042
    [No Abstract]   [Full Text] [Related]  

  • 40. [Encephalopathy in patients with terminal renal insufficiency undergoing treatment with regular hemodialysis].
    Nikiforov AS; Soldatova SA; Potomskaia LE; Vinarskaia EN; Ermolenko VM
    Ter Arkh; 1977; 49(7):67-70. PubMed ID: 898080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.